Koyfin Home > Directory > Health Care > Adma Biologics > EV / EBITDA (ltm)

Adma Biologics EV / EBITDA (ltm) Chart (ADMA)

Adma Biologics annual/quarterly EV / EBITDA (ltm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Adma Biologics Market Cap for the quarter ending March 03, 2018 was $208m a 54.25% increase of 113m year over year
  • Adma Biologics Price / Book for the quarter ending March 03, 2018 was 5.17 a -360.96% decrease of -18.66 year over year
  • Adma Biologics Enterprise Value for the quarter ending March 03, 2018 was $206m a 49.35% increase of 101m year over year
View Chart On Koyfin